The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,764.00
Bid: 1,763.50
Ask: 1,764.00
Change: 30.50 (1.76%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,765.50
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks gain ahead of central bank announcements

Thu, 04th Oct 2012 08:23

- Investors await BoE and ECB decisions, FOMC minutes- Tate & Lyle jumps after Credit Suisse upgrades- Halfords appoints new CEO after strong Q2European stock markets have opened with moderate gains ahead of what is likely to be a busy day on the economic front, with rate decisions due out from the Bank of England (BoE) and European Central Bank (ECB) later today, as well as the minutes of the latest Federal Reserve meeting.The BoE's Monetary Policy Committee (MPC) is set to reveal whether it has made any alterations to its key interest rate and asset purchase programme (also known as quantitative easing, or QE) at noon.The smart money is on there being no change, with the interest rate staying at 0.5% and the asset purchase (quantitative easing, or QE) pot staying at £375bn. However, some are expecting an increase in QE and a 25 basis point rate cut in November.The ECB is also expected to remain in 'wait-and-see' mode when it reveals its policy decision after midday. Analysts believe that the ECB will wait for Spain to make the next move considering that it already announced its bond purchase plan for ailing countries that request aid. The key interest rate currently stands at 0.75% after it was cut by 25 basis points early in the year. The deposit rate is at 0%. Analyst Craig Erlam from Alpari said: "There's been a lack of volatility in the markets in recent weeks as investors look beyond central banks to the governments for reassurance on the next step in the debt crisis. The uncertainty surrounding Spain has left investors unsure on how to position themselves as we approach near end. Given a lack of details out of the eurozone, there is a hope that the ECB will give us some valuable insight into this."Meanwhile, the Federal Open Market Committee (FOMC) minutes are also on the agenda for later. Analyst Moyeen Islam from Barclays Research said this morning that the minutes should provide more "granularity regarding what the Fed may judge to be a 'sustainable improvement' in the labour market that would underpin any decision to end the current open-ended commitment to asset purchases.FTSE 100: Tate & Lyle gains after broker upgradeSweeteners and food products group Tate & Lyle was the high riser in early trading after Credit Suisse raised its recommendation for the stock from 'neutral' to 'outperform'. The broker said: "There is no easy way to value Tate & Lyle, but it does seem to us to be a better business for all the changes we have seen and that this is not reflected in the share price (which is down 8% year to date versus a staples sector up 18%)."Evraz fell after acquiring an indirect controlling interest in OJSC Raspadskaya, one of Russia's largest producers of coking coal and a supplier to the Russian steel firm.Pharmaceuticals behemoth GlaxoSmithKline gained after saying its joint venture company, Shionogi-ViiV Healthcare, has completed an initial clinical registration package for dolutegravir, its treatment for HIV patients.Supermarket peers Tesco and Sainsbury were among the stocks in the red following their results and trading update yesterday, respectively. Exane BNP Paribas reduced its target price for Tesco this morning from 325p to 300p and reiterated its 'underperform' rating on the shares. FTSE 250: Halfords surges after impressive Q2, new CEO appointmentCar and bike parts retailer Halfords jumped after appointing a new Chief Executive Officer following the abrupt departure of David Wild in the summer, as it revealed that full-year profits would be at the top end of guidance after a strong second quarter.The company expects pre-tax profit to be in the region of £40-42m in the first half on the back of its second quarter performance and an acceleration of operating cost investment. The consensus estimate currently stands at just £35.8m. Fashion chain Ted Baker was in demand after saying that the reaction to its autumn/winter collections has been positive as it unveiled a solid first-half trading performance. FTSE 100 - RisersTate & Lyle (TATE) 691.50p +2.52%Standard Chartered (STAN) 1,421.00p +1.21%Prudential (PRU) 833.00p +1.09%Carnival (CCL) 2,336.00p +0.99%InterContinental Hotels Group (IHG) 1,655.00p +0.98%Barclays (BARC) 222.30p +0.93%International Consolidated Airlines Group SA (CDI) (IAG) 165.20p +0.92%Royal Bank of Scotland Group (RBS) 260.40p +0.89%Diageo (DGE) 1,795.00p +0.84%ITV (ITV) 91.95p +0.82%FTSE 100 - FallersEvraz (EVR) 239.60p -3.11%BHP Billiton (BLT) 1,929.00p -0.72%Tesco (TSCO) 325.75p -0.67%G4S (GFS) 266.50p -0.56%BG Group (BG.) 1,302.00p -0.53%BP (BP.) 436.85p -0.50%CRH (CRH) 1,183.00p -0.50%Johnson Matthey (JMAT) 2,406.00p -0.46%Amec (AMEC) 1,145.00p -0.43%British Land Co (BLND) 521.00p -0.29%FTSE 250 - RisersHalfords Group (HFD) 302.00p +13.53%Ted Baker (TED) 945.00p +3.45%Victrex (VCT) 1,372.00p +3.08%Stobart Group Ltd. (STOB) 115.40p +2.58%Ocado Group (OCDO) 67.70p +2.27%Rentokil Initial (RTO) 84.85p +2.23%Computacenter (CCC) 385.00p +2.18%Paragon Group Of Companies (PAG) 212.30p +2.07%Lonmin (LMI) 548.00p +2.05%FirstGroup (FGP) 197.30p +2.02%FTSE 250 - FallersRank Group (RNK) 146.90p -2.39%Hansteen Holdings (HSTN) 76.30p -2.18%Carpetright (CPR) 630.00p -2.10%IP Group (IPO) 118.60p -1.58%JD Sports Fashion (JD.) 709.00p -1.53%Dechra Pharmaceuticals (DPH) 583.00p -1.10%Bovis Homes Group (BVS) 495.20p -1.06%Kenmare Resources (KMR) 39.75p -1.00%Petra Diamonds Ltd.(DI) (PDL) 115.20p -0.95%Utilico Emerging Markets Ltd (DI) (UEM) 160.12p -0.86%BC
More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.